CCL19 has been reported to be highly expressed in the lung tissue of patients with IPF, which facilitates the recruitment and accumulation of dendritic cells to fibrotic lung and sustains chronic inflammation, driving IPF development (36). Here, CCL19 is linked to idiopathic pulmonary fibrosis.